Storebo O, Storm M, Ribeiro J, Skoog M, Groth C, Callesen H
Cochrane Database Syst Rev. 2023; 3:CD009885.
PMID: 36971690
PMC: 10042435.
DOI: 10.1002/14651858.CD009885.pub3.
Sandersleben H, Dangel O, Fischer R, Ruhmann M, Huss M
Scand J Child Adolesc Psychiatr Psychol. 2021; 9:73-86.
PMID: 33928056
PMC: 8077785.
DOI: 10.21307/sjcapp-2021-009.
Robbins T
Dialogues Clin Neurosci. 2019; 21(3):301-308.
PMID: 31749654
PMC: 6829171.
DOI: 10.31887/DCNS.2019.21.3/trobbins.
Padilha S, Virtuoso S, Tonin F, Borba H, Pontarolo R
Eur Child Adolesc Psychiatry. 2018; 27(10):1335-1345.
PMID: 29460165
DOI: 10.1007/s00787-018-1125-0.
Punja S, Shamseer L, Hartling L, Urichuk L, Vandermeer B, Nikles J
Cochrane Database Syst Rev. 2016; 2:CD009996.
PMID: 26844979
PMC: 10329868.
DOI: 10.1002/14651858.CD009996.pub2.
Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD).
Storebo O, Ramstad E, Krogh H, Nilausen T, Skoog M, Holmskov M
Cochrane Database Syst Rev. 2015; (11):CD009885.
PMID: 26599576
PMC: 8763351.
DOI: 10.1002/14651858.CD009885.pub2.
Impact of Attention-Deficit Hyperactivity Disorder on School Performance: What are the Effects of Medication?.
Baweja R, Mattison R, Waxmonsky J
Paediatr Drugs. 2015; 17(6):459-77.
PMID: 26259966
DOI: 10.1007/s40272-015-0144-2.
Minimizing adverse events while maintaining clinical improvement in a pediatric attention-deficit/hyperactivity disorder crossover trial with dextroamphetamine and methylphenidate.
Ramtvedt B, Aabech H, Sundet K
J Child Adolesc Psychopharmacol. 2014; 24(3):130-9.
PMID: 24666268
PMC: 3993015.
DOI: 10.1089/cap.2013.0114.
Clinical gains from including both dextroamphetamine and methylphenidate in stimulant trials.
Ramtvedt B, Roinas E, Aabech H, Sundet K
J Child Adolesc Psychopharmacol. 2013; 23(9):597-604.
PMID: 23659360
PMC: 3842881.
DOI: 10.1089/cap.2012.0085.
How effective are drug treatments for children with ADHD at improving on-task behaviour and academic achievement in the school classroom? A systematic review and meta-analysis.
Prasad V, Brogan E, Mulvaney C, Grainge M, Stanton W, Sayal K
Eur Child Adolesc Psychiatry. 2012; 22(4):203-16.
PMID: 23179416
DOI: 10.1007/s00787-012-0346-x.
Amfetamine and methylphenidate medications for attention-deficit/hyperactivity disorder: complementary treatment options.
Hodgkins P, Shaw M, Coghill D, Hechtman L
Eur Child Adolesc Psychiatry. 2012; 21(9):477-92.
PMID: 22763750
PMC: 3432777.
DOI: 10.1007/s00787-012-0286-5.
Academic, behavioral, and cognitive effects of OROS® methylphenidate on older children with attention-deficit/hyperactivity disorder.
Wigal S, Wigal T, Schuck S, Brams M, Williamson D, Armstrong R
J Child Adolesc Psychopharmacol. 2011; 21(2):121-31.
PMID: 21488750
PMC: 3080768.
DOI: 10.1089/cap.2010.0047.
Comparing the efficacy of stimulants for ADHD in children and adolescents using meta-analysis.
Faraone S, Buitelaar J
Eur Child Adolesc Psychiatry. 2009; 19(4):353-64.
PMID: 19763664
DOI: 10.1007/s00787-009-0054-3.
Childhood and adolescent hyperactivity-inattention symptoms and academic achievement 8 years later: the GAZEL Youth study.
Galera C, Melchior M, Chastang J, Bouvard M, Fombonne E
Psychol Med. 2009; 39(11):1895-906.
PMID: 19335935
PMC: 2797029.
DOI: 10.1017/S0033291709005510.
Psychostimulant treatment and the developing cortex in attention deficit hyperactivity disorder.
Shaw P, Sharp W, Morrison M, Eckstrand K, Greenstein D, Clasen L
Am J Psychiatry. 2008; 166(1):58-63.
PMID: 18794206
PMC: 2700349.
DOI: 10.1176/appi.ajp.2008.08050781.
Reading and spelling deficits among children attending a psychiatric day treatment program.
Kotsopoulos S, Walker S, Beggs K, Jones B, Kotsopoulos A, Patel P
Eur Child Adolesc Psychiatry. 1996; 5(2):83-92.
PMID: 8814414
DOI: 10.1007/BF01989500.
